557 results match your criteria Australian Prescriber[Journal]


Erratum: Extemporaneously compounded medicines [Correction].

Authors:

Aust Prescr 2017 Jun 10;40(3):119. Epub 2017 May 10.

[This corrects the article DOI: 10.18773/austprescr.2017. Read More

View Article and Full-Text PDF

The assessment of severe cutaneous adverse drug reactions.

Aust Prescr 2022 Apr 1;45(2):43-48. Epub 2022 Apr 1.

McGill University Health Centre, McGill University, Montreal, Quebec, Canada.

Severe cutaneous adverse drug reactions include Stevens-Johnson syndrome, toxic epidermal necrolysis and acute generalised exanthematous pustulosis. These eruptions are a type of delayed hypersensitivity reaction and can be life-threatening. The assessment of a severe cutaneous drug reaction requires a detailed clinical history and examination to identify the culprit drug and evaluate the allergy. Read More

View Article and Full-Text PDF

Statin doses after acute coronary syndrome.

Authors:

Aust Prescr 2022 Apr 1;45(2):42. Epub 2022 Apr 1.

View Article and Full-Text PDF

Drugs for pain management in frail older people.

Authors:

Aust Prescr 2022 Apr 1;45(2):41. Epub 2022 Apr 1.

View Article and Full-Text PDF

Nirmatrelvir and ritonavir for COVID-19.

Authors:

Aust Prescr 2022 Apr 28;45(2):61. Epub 2022 Feb 28.

View Article and Full-Text PDF

Molnupiravir for COVID-19.

Authors:

Aust Prescr 2022 Apr 28;45(2):60. Epub 2022 Feb 28.

View Article and Full-Text PDF

Casirivimab and imdevimab for COVID-19.

Authors:

Aust Prescr 2022 Apr 28;45(2):58-59. Epub 2022 Feb 28.

View Article and Full-Text PDF

Fostemsavir for HIV-1 infection.

Authors:

Aust Prescr 2022 Apr 4;45(2):63-64. Epub 2022 Mar 4.

View Article and Full-Text PDF

Troponins in myocardial infarction and injury.

Aust Prescr 2022 Apr 1;45(2):53-57. Epub 2022 Apr 1.

Australian University Medical School, Canberra.

Troponins are proteins that are integral components of the contractile mechanism of muscle, including cardiac muscle. Cardiac troponins Iand T can be detected in the blood of most people after puberty, at concentrations reflecting cardiac mass, sex and age. Current laboratory assays are approximately 1000 times more sensitive than those used previously. Read More

View Article and Full-Text PDF

Lanadelumab for hereditary angioedema.

Authors:

Aust Prescr 2022 Apr 4;45(2):65. Epub 2022 Mar 4.

View Article and Full-Text PDF

Ravulizumab for paroxysmal nocturnal haemoglobinuria.

Authors:

Aust Prescr 2022 Apr 4;45(2):66. Epub 2022 Mar 4.

View Article and Full-Text PDF

Medicines for long-term obesity management.

Authors:
Joseph Proietto

Aust Prescr 2022 Apr 1;45(2):38-40. Epub 2022 Apr 1.

Obesity is always genetic or epigenetic in origin in an obesogenic environment. Dietary therapy is required for weight loss. Drugs to suppress hunger and increase satiety may assist while losing weight and are essential for most patients in the weight maintenance period. Read More

View Article and Full-Text PDF

Antidepressants in adolescence.

Authors:
Phillip Hazell

Aust Prescr 2022 Apr 1;45(2):49-52. Epub 2022 Apr 1.

In adolescence, antidepressants are second-line treatment options after psychological therapy for anxiety and obsessive compulsive disorder. They may be first- or second-line options for severe cases of major depressive disorder. The response to antidepressant treatment is generally good for anxiety and obsessive compulsive disorder, but is less convincing for major depressive disorder. Read More

View Article and Full-Text PDF

Erratum: Antipsychotic switching tool [Update 4].

Authors:

Aust Prescr 2022 Feb 1;45(1):35. Epub 2022 Feb 1.

[This corrects the article DOI: 10.18773/austprescr.2019. Read More

View Article and Full-Text PDF
February 2022

Voretigene neparvovec for inherited retinal dystrophy.

Authors:

Aust Prescr 2022 Feb 10;45(1):33. Epub 2021 Dec 10.

View Article and Full-Text PDF
February 2022

Satralizumab for neuromyelitis optica spectrum disorder.

Authors:

Aust Prescr 2022 Feb 10;45(1):32. Epub 2021 Dec 10.

View Article and Full-Text PDF
February 2022

Lurbinectedin for small cell lung cancer.

Authors:

Aust Prescr 2022 Feb 10;45(1):31. Epub 2021 Dec 10.

View Article and Full-Text PDF
February 2022

Lemborexant for insomnia.

Authors:

Aust Prescr 2022 Feb 10;45(1):29-30. Epub 2021 Dec 10.

View Article and Full-Text PDF
February 2022

Esketamine hydrochloride for treatment-resistant depression.

Authors:

Aust Prescr 2022 Feb 10;45(1):27-28. Epub 2021 Dec 10.

View Article and Full-Text PDF
February 2022

Burosumab for X-linked hypophosphataemia.

Authors:

Aust Prescr 2022 Feb 10;45(1):25-26. Epub 2021 Dec 10.

View Article and Full-Text PDF
February 2022

Home oxygen therapy.

Aust Prescr 2022 Feb 1;45(1):21-24. Epub 2022 Feb 1.

Austin Health, Melbourne.

Long-term home oxygen therapy improves survival in patients with chronic obstructive pulmonary disease and persistent, severe hypoxaemia. It is uncertain that this benefit extends to patients with other chronic lung diseases. Oxygen is a treatment for hypoxaemia, not breathlessness. Read More

View Article and Full-Text PDF
February 2022

Cluster headache in adults.

Aust Prescr 2022 Feb 1;45(1):15-20. Epub 2022 Feb 1.

Department of Neurology, Alfred Hospital.

Cluster headache is characterised by attacks of very severe, unilateral headache lasting 15-180 minutes, up to eight times per day. The attacks are associated with cranial autonomic symptoms on the same side and a sense of agitation or restlessness First-line acute abortive treatments include intranasal or subcutaneous sumatriptan or high-flow oxygen. Neuromodulation may benefit some patients First-line preventive therapy is high-dose verapamil. Read More

View Article and Full-Text PDF
February 2022

Optimal use of smoking cessation pharmacotherapy.

Authors:
Colin Mendelsohn

Aust Prescr 2022 Feb 1;45(1):10-14. Epub 2022 Feb 1.

Double Bay, Sydney.

The most effective intervention for stopping smoking is a combination of professional counselling and pharmacotherapy. Medicines are recommended for all smokers who are motivated to quit and are nicotine dependent. Combination nicotine replacement therapy with a patch and an oral product is more effective than the patch alone. Read More

View Article and Full-Text PDF
February 2022

Cariprazine pharmacokinetics.

Authors:

Aust Prescr 2022 Feb 1;45(1). Epub 2022 Feb 1.

View Article and Full-Text PDF
February 2022

Complementary medicines: an alternative view.

Authors:

Aust Prescr 2022 Feb 1;45(1). Epub 2022 Feb 1.

View Article and Full-Text PDF
February 2022

Pharmacological management of chronic non-cancer pain in frail older people.

Authors:
Gloria Wong

Aust Prescr 2022 Feb 1;45(1):2-7. Epub 2022 Feb 1.

Department of Internal Medicine and Aged Care, Royal Brisbane and Women's Hospital.

Chronic non-cancer pain is a common problem among older people and has a significant impact on their quality of life. Medical comorbidities and polypharmacy are often additional challenges in managing these patients Appropriate assessment of chronic non-cancer pain is important for the development of a patient-centred, goal-directed management plan. When assessing patients with cognitive impairment, modified communication strategies and validated pain assessment tools can be useful The quantity and quality of the evidence supporting individual drugs in the management of chronic non-cancer pain varies and studies focused on frail older people are limited. Read More

View Article and Full-Text PDF
February 2022

Erratum: The safety of commonly used vitamins and minerals [Correction].

Authors:

Aust Prescr 2021 Dec 5;44(6):209. Epub 2021 Nov 5.

[This corrects the article DOI: 10.18773/austprescr.2021. Read More

View Article and Full-Text PDF
December 2021